TargEDys
Solutions to regulate appetite
TargEDys has raised €10M across 3 funding rounds from 5 investors, most recently a Series A round in Apr 2017. Based in Rouen, France; founded 2015; active in Healthtech. Data as of 4 Nov 2026.
Total raised
€10M
€10,400,000
Funding rounds
3
Investors
5
distinct backers
Active since
2016-04
latest 2017-04
Funding by year
EUR raised per yearTargEDys — funding by year — interactive chart.
Data table
| TargEDys — funding by year | |
|---|---|
| 2016 | €5.8M |
| 2017 | €4.6M |
Signals
High confidenceRaise-next likelihood9
base rate 44% for Series A
- ▼ Dormant (no round in 3+ cohort gaps)
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood9
base rate 11% (2+ rounds)
- ▲ 11y since founding (typical exit age)
- ▼ No recent equity round (debt-only or quiet)
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
3 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2017-04-12 | Series A | €3.5M | Bpifrance,Zaluvida | View deal → |
| 2017-03-01 | Early VC | €1.1M | Bpifrance | View deal → |
| 2016-04-01 | Series A | €5.8M | NCI Information Systems,Pontifax Funds,Seventure Partners | View deal → |
Related news
Similar companies
same sector, similar size- Ixaltis€11MFrance · Healthtech
- AblaCare€10MFrance · Healthtech
- Igyxos€7.5MFrance · Healthtech
- NH TherAguix€13MFrance · Healthtech
- Surgivisio€11MFrance · Healthtech
- TxCell€11MFrance · Healthtech
Global coverage: FundingData